Article
CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases.
Human pathology - 1 Aug 2021
Rozenova Krasimira A, Jevremovic Dragan, Reichard Kaaren K, Nguyen Phuong, Otteson Gregory E, Timm Michael M, Horna Pedro, Olteanu Horatiu, Shi Min
Abstract excerpt
T-lymphoblastic leukemia/lymphoma (T-ALL/LBL) is a rare acute leukemia that expresses cytoplasmic CD3 (cCD3) and frequently lacks surface CD3. Given that routine flow cytometric testing for cCD3 may not be feasible and cCD3 interpretation may be difficult, we investigate if surface CD2 and/or CD7 expression on blasts can be used by flow cytometry to screen for T-lineage acute leukemia. We retrospectively reviewed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
